Printer Friendly

Analysis of Apoptosis in Cultured Human Vitrified Ovarian Tissue in the Presence of Leukemia Inhibitory Factor.


An alternative technique for fertility preservation in young women is the cryopreservation of ovarian tissue by vitrification and an increased attention has been focused recently on this technique. Vitrification--a process of solidification without ice crystallization--provides better preservation for ovarian tissue with respect to follicular integrity and function (1-5).

In vitro culture of human ovarian tissue following cryopreservation is recommended to allow follicular development. The viability of cultured human ovarian tissue is improved by the addition of various growth factors to the culture media (6-10).

Leukemia inhibitory factor (LIF) is a glycoprotein that belongs to the interleukin-6 family; it is involved in various biological activities, including cell growth and differentiation (11). LIF has a critical role as a survival factor in several cell types during in vitro culture, acting via phosphoinositide 3-kinase pathways (12, 13). LIF induces the expression of anti-apoptotic molecules such as Bcl-2 and also plays an essential role in protective mechanisms against oxidative injury during induced cell apoptosis (14). Moreover, its anti-apoptotic effects on several cell types, such as myocytes, oligodendrocytes and mouse embryonic stem cells, have been demonstrated (13, 15-19). It has been reported that LIF is important for the promotion of in vitro folliculogenesis in the mouse (20, 21), and it may improve in vitro growth and maturation of murine vitrified preantral follicles (21). However, to the authors' knowledge, there has been no report describing supplementation of culture media with LIF to provide enhancement of human in vitro follicular growth as a consequence of its anti-apoptotic effect.

Controversial reports have been published regarding the occurrence of apoptotic cell death immediately after warming of vitrified human ovarian tissue (22-25). It has been shown that vitrification and ultrarapid protocols did not affect the incidence of apoptosis in human ovarian tissue after warming and 24 hr of in vitro culture (25), but at the molecular level, there were some slight differences in the level of expression of apoptosis-related genes between the vitrified and non-vitrified groups (26). However, apoptosis is a dynamic process and it may need more time to affect the long-term survival of tissue or follicular development. There have been no reports in the literature describing an analysis of the incidence of apoptosis during long-term culture of vitrified human ovarian tissue.

Thus, the objective of this study was to investigate firstly the effect of vitrification, and secondly LIF supplementation as an anti-apoptotic and survival factor on the follicular development and incidence of apoptosis after long-term culture of human ovarian tissue. The assessments were done at the morphological, ultrastructural, biochemical, and molecular levels.


Chemicals: Unless mentioned otherwise, all reagents and chemicals used in the present study were purchased from Sigma-Aldrich (St, Louis, USA).

Human ovarian tissue: Human ovarian tissue was obtained from 25 healthy women aged between 24 and 35 years after caesarean section. The women gave their consent, and the procedure was approved by the Ethics Committee of Tarbiat Modares University (Ref. No. 5274856). Ovarian biopsy specimens approximately 5x5x1 [mm.sup.3] were placed in tubes containing pre-warmed and equilibrated Leibovitz L-15 medium with 10 mg/ml human serum albumin (HSA; Biotest, Germany), 100 IU/ml penicillin and 100 mg/ml streptomycin; the samples were transferred to the laboratory within 1-2 hr on ice. The ovarian cortexes were cut into small pieces (2.5x1x1 [mm.sup.3]) under a sterile laminar air flow in Leibovitz L-15 medium.

Experimental design: After preparation of the ovarian biopsy specimens, they were cut into several fragments then these tissue fragments were divided randomly in both non-vitrified and vitrified groups. After warming the vitrified samples, the tissue fragments were cultured in the presence or absence of LIF in both groups (Vitrified and non-vitrified groups). The vitrified and non-vitrified human ovarian tissues were subjected to in vitro culture for 14 days then the assessment of apoptosis was done by several techniques. Thus, there were four groups including non-vitrified--LI[F.sup.-], vitrified--LI[F.sup.-], vitrified--LI[F.sup.+] and non-vitrified--LI[F.sup.+] groups. To compare the same tissue under different conditions, fragments of each biopsy specimen were included in almost all experimental groups. The apoptosis induced mice thymic tissue and apoptosis induced human ovarian tissue were used in this study as technical controls.

Vitrification and warming procedures: The vitrification procedure was based on a method used previously (27), with some modifications. The vitrification solution was EFS40% containing 40% ethylene glycol (EG; v/v), 30% ficoll 70 (w/v), and 0.5 M sucrose supplemented with 0.21% HSA. Ovarian cortical pieces were dehydrated in the vitrification solution for 5 min, with three changes. Subsequently, the tissues were loaded into cryovials with a minimal amount of vitrification solution, exposed to nitrogen vapor phase for 30 seconds and finally plunged into liquid nitrogen and stored for one month.

The cryovials containing vitrified tissues were warmed at room temperature for 20 seconds and then placed in a 37[degrees]C water bath until melted. The warmed tissues were rinsed in solutions of 1, 0.5 and 0.25 M sucrose, respectively, at room temperature for 5 min. They were equilibrated in Mc Coy's culture medium for 30 min before any assessment.

Long-term tissue culture conditions: The tissues were cultured (n=45 fragments for each group) separately on inserts (0.4 [micro]m Millicell Culture Plate Inserts, Millipore, France) in six-well culture dishes containing 2 ml of McCoy's culture medium (pH=7.2-7.4) supplemented with 1.25% HSA, 1% insulin-transferrin-selenium (ITS), 100 IU/ml penicillin, 100 mg/ml streptomycin, 2 mM glutamine, 0.3 IU/ml human recombinant follicle-stimulating hormone (rFSH or Gonal-f; Serono, Switzerland), and 50 g/ml ascorbic acid at 37[degrees]C in an atmosphere of 5% C[O.sub.2] in air for 14 days (10). In the LIF treated groups, 50 ng/ml recombinant human LIF was added to the culture medium (20). Subsequently, 500 [micro]l of medium was collected from each well in all groups every 2 days and replaced with fresh medium. The media collected at 2 and 14 days of cultivation were stored at--20[degrees]C for hormonal assay.

Apoptosis induction in tissue: For preparation of technical positive control groups, the apoptosis was induced in the thymus tissue of 3-week-old NMRI (National Medical Research Institute) mice by giving an intraperitoneal injection of 10 mg/kg of dexamethasone (25). Approval for this study was obtained from the Animal Research Ethical Committee of Tarbiat Modares University. After 16 hr, the mice (n=9) were sacrificed by cervical dislocation; their thymus tissue was dissected and stored at -80[degrees]C for caspase-3/7 and TUNEL assays.

Apoptosis induction in human ovarian tissue: Fresh human ovarian tissue samples (n=3) were cultured in media supplemented with 0.5 mg/ml acinomycin D for 19 hr to induce apoptosis (28), as a control for DNA laddering assessment. The tissues were stored at--80[degrees]C until assessment.

Light microscopy (LM): The human ovarian tissue samples (n=5 in each subgroup) were fixed in 4% formaldehyde and paraffin, serially cut into 5 [micro]m sections, and every 10th section was stained with hematoxylin and eosin and assessed under a light microscope. The developmental stages of the follicles were classified by the shape and number of layers of granulosa cells (25).

Hormonal assay: The concentrations of 17-[beta] estradiol, progesterone and DHEA (Dehydroepiandrostrone) were analyzed using kits (Monobind, USA; DiaPlus, USA; Monobind, USA, respectively) (n=5 for each hormonal assessment at day 2 or 14 for each subgroup).

Electron microscopy: The tissue samples (n=5 in each subgroup) were fixed in 2.5% glutaraldehyde in phosphate-buffered saline (PBS, pH=7.4) for 2 hours, and post-fixed with 1% osmium tetroxide in the same buffer for 2 hr. After dehydration in an ascending series of ethanol, specimens were placed in acetone and embedded in epoxy resin. Thin sections were stained with uranyl acetate and lead citrate then examined using a transmission electron microscope (Zeiss, 911, Germany).

TUNEL assay: The human ovarian tissues and apoptosis-induced mouse thymus tissue were fixed in 4% formaldehyde and paraffin, serially cut into 5 [micro]m sections and five sections were selected randomly for TUNEL assay (n=3 for each subgroup). The sections were stained according to the instructions of the kit (In Situ Cell Death Detection Kit, Roche, Germany). The slides were rinsed in PBS three times and examined using a fluorescence microscope (Zeiss, Axiophot, Germany). The photographs of each section were prepared and imported into Image J software (National Institutes of Health, Bethesda, USA), and the TUNEL positive signals per 1000 [micro][m.sup.2] of ovarian tissue in three sections from each experimental subgroups were counted.

Evaluation of apoptosis using DNA laddering: After 14 days of culture, the human ovarian tissues and apoptosis-induced tissues were assessed for DNA laddering (n=3 in each subgroup). Total DNA was extracted from the tissues separately, according to the instruction of the kit (Apoptotic DNA Ladder Kit 1 835 246 Roche, Germany). The DNA content was determined spectrophotometrically. To assay DNA fragmentation, each lane of a 1% agarose gel was loaded with 10 [micro]g DNA and electrophoresed for 45 min at 80 volts.

Caspase-3/7 assay: The caspase-3/7 activity of tissues from all experimental groups and dexamethasone treated mouse thymus tissue (n[less than or equal to]6 for each subgroup) was analyzed using the Caspase-Glu 3/7 Assay kit (Promega, G8020, UK), following the manufacturer's instructions. The tissue extracts were cleared by centrifugation at 13000 rpm for 15 min at 4[degrees]C and the supernatants were divided into equal volumes for the total protein and caspase-3/7 assays. Total protein concentrations were determined by the Bradford technique (Bio-Rad). Diluted (10 [micro]g/ml) extract was mixed with Caspase-Glo[R] Reagent in test tubes and incubated for 1 hr at room temperature. Following this, samples were put in a Sirius single tube luminometer (Berthold Detection Systems GmbH, Germany) and the reading on the luminometer was recorded in RLU (Relative light units). The activity of caspase-3/7 per mg protein was determined as described previously (29).

RNA extraction and cDNA synthesis: Total RNA was extracted from the human ovarian tissue samples and apoptosis-induced human ovarian tissues (n=3 in each subgroup) using an RNeasy Mini Kit (Qiagen, Valencia, CA, USA), according to the manufacturer's instructions. Using oligo dT, RNA was reverse-transcribed by RevertAid M-MuLV reverse transcriptase using the specified primers (Table 1); the GAPDH gene was used as an internal control (26).

Real time RT-PCR: After cDNA synthesis, real time RT-PCR was performed on an Applied Biosystem real time thermal cycler using a Quanti-Tect SYBR Green RT-PCR kit (Applied Biosystems, UK).

After completing the PCR run, melt curve analysis was used to confirm the amplified product. For each sample, the reference gene (GAPDH) and the target genes were amplified in the same run. The real time thermal conditions included a holding step: 95[degrees]C, 5', cycling step: 95[degrees]C 15', 58[degrees]C 30', 72[degrees]C 30', and the cycle was continued by a melt curve step: 95[degrees]C 15', 60[degrees]C 1', 95[degrees]C 15'. Relative quantification of target genes was determined using the Pfaffl method (30). The real time RT-PCR experiments were repeated three times.

Statistical analysis: Quantitative variables were expressed as mean[+ or -]SE. One-way ANOVA was used to compare the proportion of follicles among groups. Mean hormone levels were compared using independent t-tests and the day 2 and day 14 in each groups were compared with paired t-test. The results of the real time RT-PCR were compared by one-way ANOVA and the post hoc Tukey test. The p-values of <0.05 were considered significant.


The morphology of cultured human ovarian tissues in the vitrified and non-vitrified groups in the presence and absence of LIF, using H&E staining, is shown in figure 1A-D. The light microscopic observations showed the normal structure of follicles in cultured ovarian tissue. Some damaged follicles with disorganized granulosa cells were found in LIF non-treated group (Figure 1C, white arrow).

The percentage of normal follicles at different developmental stages in all groups is shown in table 2. There was a significant difference in the proportion of normal follicles between the non-vitrified--LI[F.sup.-] and vitrified--LI[F.sup.-] groups (p<0.05) but no significant difference was observed between the vitrified--LI[F.sup.+] and non-vitrified--LI[F.sup.+] groups. The rates of normal follicles were higher in both LIF-treated groups than in non-LIF treated group (p<0.05). There was no significant difference in the proportions of primordial, primary and growing follicles between the non-vitrified and vitrified groups but these rates differed significantly in the LIF-supplemented groups in comparison with non-LIF treated group (p<0.05).

Hormonal assay: The levels of hormones were significantly changed in all groups of study on day 14 than day 2 of culture period (Table 3). In all LIF-treated groups, the levels of 17-[beta] estradiol and progesterone were higher and the level of DHEA was lower than non-LIF treated groups (p<0.05) at the end of culture period. However, there was no significant difference between vitrified and non-vitrified groups.

Ultrastructural observations: The ultrastructure of human ovarian tissue at the end of cultivation period is shown in figure 2. The fine structure of all human ovarian culture groups was similar. The ultrastructure of normal follicles was seen in all groups of study including no chromatin condensation, shrinkage of cell membrane and cytoplasmic vacuoles. The oocytes had a euchromatin nucleus at the germinal vesicle stage and the granulosa and theca cell nuclei showed peripheral aggregations of heterochromatin.

TUNEL assay: The TUNEL-positive cells were found in stromal tissue of cultured ovaries but the TUNEL signals were not seen in follicles of studied groups (Figure 3A-D). TUNEL signals per 1000 [micro][m.sup.2] of ovarian tissue in the non-vitrified--LI[F.sup.-], vitrified--LI[F.sup.-], non-vitrified--LI[F.sup.+] and vitrified--LI[F.sup.+] groups were 5.22[+ or -]0.23%, 6.21[+ or -]0.25%, 2.14[+ or -]0.19% and 2.39[+ or -]0.22% per 1000 [micro][m.sup.2], respectively. The number of apoptotic signals in vitrified samples was not significantly different from that in non-vitrified samples, but it was significantly lower in all LIF-treated groups than other groups (p<0.05). Mouse thymus tissue, used as a positive control, showed a high number of TUNEL signals per 1000 [micro][m.sup.2] (8.62[+ or -]0.32).

DNA laddering: Gel electrophoresis of genomic DNA from the apoptosis induced control human ovarian tissue showed characteristic pattern of DNA laddering (Figure 3E). Moreover, no DNA laddering pattern was observed on gel electrophoresis of all cultured groups (Figure 3E).

Caspase-3/7 assay: A high level of caspase-3/7 activity was observed in apoptosis-induced mouse thymus, used as the positive control. This enzyme activity was significantly lower in both LIF-treated groups than their control groups (p<0.05), but there were no significant differences between the non-vitrified and vitrified groups in this regard (Table 4).

Expression of apoptosis-related genes in cultured human ovarian tissue: The ratio expression of pro-apoptotic (Bax, p53, Fas, FasL, caspase3 and 8) and anti-apoptotic (Bcl-2, BIRC5) genes to housekeeping gene (GAPDH) in all groups is shown in table 5 and table 6, respectively. Among the studied genes, the expression of Bcl-2, Bax, Bax/Bcl-2, caspase8 and BIRC5 was not significantly different in the non-vitrified and vitrified groups, but the expression of caspase3, p53, Fas and FasL was significantly higher in the absence of LIF in the vitrified group in comparison with the non-vitrified group (p<0.05).

In both LIF-treated (Vitrified and non-vitrified) groups, the expression ratio of pro-apoptotic genes (Fas, FasL, caspase 3 and 8, and p53) was lower and the expression of anti-apoptotic gene (BIRC5) was higher than non-LIF-treated groups (p<0.05).


Our observations showed a similar percentage of morphologically normal follicles in non-vitrified and vitrified groups and demonstrated that this vitrification technique had no significant effect on the viability of human ovarian follicles in long-term culture. Therefore, this method may allow preservation of the fine structure and integrity of different cells in ovarian tissue.

It was reported previously that the morphology of the human ovarian tissues was well preserved after short-term culture (25), and similar observations have been made by others (24, 28). However, some cryodamage to oocytes and follicular cells has been shown in vitrified human ovarian tissue (22, 31, 32, 33). These differences may be related to the cryopreservation protocols used, the type of cryoprotectants, and other individual differences between human samples. In addition, our biochemical analysis of apoptosis, including caspase-3/7 and TUNEL assays, showed no increase in the incidence of apoptosis in the vitrified groups during the culture period. However, apoptotic cells within the stroma of ovarian tissue may represent migratory cells around the blood vessels (25) or be related to vascular endothelial cells, connective tissue cells and corpora albicans in the ovarian tissue (34).

Our data showed that LIF improved the proportion of normal follicles (p<0.05); this is the first report regarding the effect of LIF on the improvement of follicular survival and development after in vitro culture of human ovarian tissue. In addition, an increase in the proportion of growing follicles and the well preserved ultrastructure of tissue in the LIF-treated groups showed its beneficial effects on preservation of follicles in human ovarian tissues during the culture period. LIF acts as a survival and proliferation factor in several cell types via phosphoinositide 3-kinase pathways (12, 13). It may also be involved in growth initiation of human primordial follicles, acting through its receptors, which are expressed on oocytes and granulosa cells in the primary and secondary follicles of adult human ovaries (35). Similar effects on the survival and growth of follicles have been shown in other species (20, 36-38).

Fewer TUNEL signals and a low level of caspase-3/7 in LIF-treated groups, shown for the first time in this study, demonstrated that LIF may support follicular survival by decreasing the incidence of apoptosis. Similar anti-apoptotic effects of LIF on different cell types, such as embryos, stem cells and myoblasts have been shown (13, 15, 39).

Our molecular observations, showed no significant change in the expression of most pro- and anti-apoptotic genes in vitrified and non-vitrified groups, but the expression of Fas and FasL in the vitrified groups was significantly higher than the one in the non-vitrified groups. However, in our previous study, it was shown that, immediately after warming in vitrified human tissue, there was no remarkable change in the expression of apoptosis-related genes (26). It seems that some alteration in the pattern of gene expression in vitrified samples needs more time to exhibit its effect, and therefore it is not detectable just after warming but detectable after 14 days of culture.

It has been suggested that the viability and follicular development may be affected by a high level of expression of pro-apoptotic genes, which leads to cell death within ovarian tissue; more studies at the protein level are need to confirm this hypothesis. Fas and FasL induce apoptosis through activation of caspase 3 and 8 (40), and some reports have shown that FasL is capable of inducing cell apoptosis (41).

However, the level of pro-apoptotic gene expression was significantly lower and the expression ratios of anti-apoptotic genes and Bax/Bcl-2 were significantly higher in all LIF-treated groups than the non-LIF treated groups. These data suggest that LIF may support and improve the viability of cultured ovarian tissue by decreasing the level of pro-apoptotic gene expression.

Bcl-2 is expressed in granulosa cells of both fetal and adult ovaries. It has a critical role in inhibiting the granulosa cell apoptosis pathway (42). Depalo et al. demonstrated that there is a significant positive correlation between Bcl-2 and the absence of apoptosis (43). Bax is a pro-apoptotic protein which is involved in granulosa cell apoptosis (42). The ratio of Bcl-2 to Bax within the cell controls the susceptibility of that cell to any given apoptotic stimulus (4, 5). In addition, the low level of p53 gene expression in the LIF-treated groups is an index of genome integrity and hence of the functional viability of the follicle. It has been shown that p53 protein was present in apoptotic cell nuclei of atretic follicles in rat ovaries (6).


During in vitro culture of vitrified human ovarian tissue, the increasing level of E2 and P4 steroid hormones and decline in DHEA levels demon strated that the endocrine function of ovarian tissue is related to growing follicles and stromal cells especially in LIF treated groups.

Therefore, vitrification of human ovarian tissue did not increase the incidence of apoptosis at the morphological and molecular levels and that LIF may improve the survival and development of cultured follicles by decreasing the incidence of apoptosis and the expression of pro-apoptotic genes.


This work was supported by the grant from Tarbiat Modares University and Iran National Science Foundation. There is no conflict of interest.

Conflict of Interest

Authors declare no conflict of interest.


(1.) Chaput L, Gremeau AS, Vorilhon S, Pons H, Chabrot C, Greze V, et al. [Fertility preservation in oncology]. Bull Cancer. 2018;105(1):99-110. French.

(2.) Shi Q, Xie Y, Wang Y, Li S. Vitrification versus slow freezing for human ovarian tissue cryopreservation: a systematic review and meta-anlaysis. Sci Rep. 2017;7(1):8538.

(3.) Xiao Z, Zhang Y, Fan W. Cryopreservation of human ovarian tissue using the silver closed vitrification system. J Assist Reprod Genet. 2017;34(11): 1435-44.

(4.) Ladanyi C, Mor A, Christianson MS, Dhillon N, Segars JH. Recent advances in the field of ovarian tissue cryopreservation and opportunities for research. J Assist Reprod Genet. 2017;34(6):709-22.

(5.) Guzy L, Demeestere I. Assessment of ovarian reserve and fertility preservation strategies in children treated for cancer. Minerva Ginecol. 2017;69(1):57-67.

(6.) Zhou XH, Zhang D, Shi J, Wu YJ. Comparison of vitrification and conventional slow freezing for cryopreservation of ovarian tissue with respect to the number of intact primordial follicles: a meta-analysis. Medicine (Baltimore). 2016;95(39):e4095.

(7.) Ramezani M, Salehnia M, Jafarabadi M. Short term culture of vitrified human ovarian cortical tissue to assess the cryopreservation outcome: Molecular and morphological analysis. J Reprod Infertil. 2017;18 (1):162-71.

(8.) Shams Mofarahe Z, Salehnia M, Ghaffari Novin M, Ghorbanmehr N, Fesharaki MG. Expression of folliculogenesis-related genes in vitrified human ovarian tissue after two weeks in vitro culture. Cell J. 2017;19(1):18-26.

(9.) Carlsson IB, Laitinen MP, Scott JE, Louhio H, Velentzis L, Tuuri T, et al. Kit ligand and c-Kit are expressed during early human ovarian follicular development and their interaction is required for the survival of follicles in long-term culture. Reproduction. 2006;131(4):641-9.

(10.) Telfer EE, McLaughlin M, Ding C, Thong KJ. A two-step serum-free culture system supports development of human oocytes from primordial follicles in the presence of activin. Hum Reprod. 2008;23(5):1151-8.

(11.) Arici A, Oral E, Bahtiyar O, Engin O, Seli E, Jones EE. Leukaemia inhibitory factor expression in human follicular fluid and ovarian cells. Hum Reprod. 1997;12(6):1233-9.

(12.) Moon C, Liu BQ, Kim SY, Kim EJ, Park YJ, Yoo JY, et al. Leukemia inhibitory factor promotes olfactory sensory neuronal survival via phosphoinositide 3-kinase pathway activation and Bcl-2. J Neurosci Res. 2009;87(5):1098-106.

(13.) Hunt L, Tudor E, White J. Leukemia inhibitory factor-dependent increase in myoblast cell number is associated with phosphotidylinositol 3-kinase-mediated inhibition of apoptosis and not mitosis. Exp Cell Res. 2010;316(6):1002-9.

(14.) Xu J, Li Z, Xu P, Yang Z. Protective effects of leukemia inhibitory factor against oxidative stress during high glucose-induced apoptosis in podocytes. Cell Stress Chaperones. 2012;17(4):485-93.

(15.) Furue M, Okamoto T, Hayashi Y, Okochi H, Fujimoto M, Myoishi Y, et al. Leukemia inhibitory factor as an anti-apoptotic mitogen for pluripotent mouse embryonic stem cells in a serum-free medium without feeder cells. In Vitro Cell Dev Biol Anim. 2005;41(1-2):19-28.

(16.) Slaets H, Dumont D, Vanderlocht J, Noben JP, Leprince P, Robben J, et al. Leukemia inhibitory factor induces an antiapoptotic response in oligodendrocytes through Akt-phosphorylation and up-regulation of 14-3-3. Proteomics. 2008;8(6):1237-47.

(17.) Azari MF, Profyris C, Karnezis T, Bernard CC, Small DH, Cheema SS, et al. Leukemia inhibitory factor arrests oligodendrocyte death and demyelination in spinal cord injury. J Neuropathol Exp Neurol. 2006;65(9):914-29.

(18.) Jo C, Kim H, Jo I, Choi I, Jung SC, Kim J, et al. Leukemia inhibitory factor blocks early differentiation of skeletal muscle cells by activating ERK. Biochim Biophys Acta Mol Cell Res. 2005;1743 (3):187-97.

(19.) Majumder A, Banerjee S, Harrill JA, Machacek DW, Mohamad O, Bacanamwo M, et al. Neurotrophic effects of leukemia inhibitory factor on neural cells derived from human embryonic stem cells. Stem Cells. 2012;30(11):2387-99.

(20.) Nilsson EE, Kezele P, Skinner MK. Leukemia inhibitory factor (LIF) promotes the primordial to primary follicle transition in rat ovaries. Mol Cell Endocrinol. 2002;188(1-2):65-73.

(21.) Haidari K, Salehnia M, Valoujerdi MR. The effects of different concentrations of leukemia inhibitory factor on the development of isolated preantral follicles from fresh and vitrified mouse ovaries. Iran Biomed J. 2006;10(4):185-90.

(22.) Zhou XH, Wu YJ, Shi J, Zheng SS. Cryopreservation of human ovarian tissue: Comparison of novel direct cover vitrification and conventional vitrification. Cryobiology. 2010;60(2):101-5.

(23.) Chang HJ, Moon JH, Lee JR, Jee BC, Suh CS, Kim SH. Optimal condition of vitrification method for cryopreservation of human ovarian cortical tissues. J Obstet Gynaecol Res. 2011;37(8):1092-101.

(24.) Xiao Z, Wang Y, Li L, Luo S, Li SW. Needle immersed vitrification can lower the concentration of cryoprotectant in human ovarian tissue cryopreservation. Fertil Steril. 2010;94(6):2323-8.

(25.) Salehnia M, Sheikhi M, Pourbeiranvand S, Lundqvist M. Apoptosis of human ovarian tissue is not increased by either vitrification or rapid cooling. Reprod Biomed Online. 2012;25(5):492-9.

(26.) Abdollahi M, Salehnia M, Salehpour S, Ghorbanmehr N. Human ovarian tissue vitrification/warming has minor effect on the expression of apoptosis-related genes. Iran Biomed J. 2013;17(4):179-86.

(27.) Salehnia M, Moghadam EA, Velojerdi MR. Ultrastructure of follicles after vitrification of mouse ovarian tissue. Fertil Steril. 2002;78(3):644-5.

(28.) Huang L, Mo Y, Wang W, Li Y, Zhang Q, Yang D. Cryopreservation of human ovarian tissue by solid-surface vitrification. Eur J Obstet Gynecol Reprod Biol. 2008;139(2):193-8.

(29.) Carrasco RA, Stamm NB, Patel BK. One-step cellular caspase-3/7 assay. Biotechniques. 2003;34(5): 1064-7.

(30.) Pfaffl MW. Quantification strategies in real-time PCR. In: Bustin SA, editor. AZ of quantitative PCR. USA: International University Line; 2004. p. 89-113.

(31.) Gandolfi F, Paffoni A, Papasso Brambilla E, Bonetti S, Brevini TA, Ragni G. Efficiency of equilibrium cooling and vitrification procedures for the cryopreservation of ovarian tissue: comparative analysis between human and animal models. Fertil Steril. 2006;85 Suppl 1:1150-6.

(32.) Rahimi G, Isachenko V, Todorov P, Tawadros S, Mallmann P, Nawroth F, et al. Apoptosis in human ovarian tissue after conventional freezing or vitrification and xenotransplantation. Cryo Lett. 2009; 30(4):300-9.

(33.) Dalman A, Deheshkar Gooneh Farahani NS, Totonchi M, Pirjani R, Ebrahimi B, Rezazadeh Valojerdi M. Slow freezing versus vitrification technique for human ovarian tissue cryopreservation: an evaluation of histological changes, WNT signaling pathway and apoptotic genes expression. Cryobiology. 2017;79:29-36.

(34.) Brodowska A, Laszczynska M, Starczewski A. Apoptosis in ovarian cells in postmenopausal women. Folia Histochem Cytobiol. 2007;45(2):99-105.

(35.) Abir R, Fisch B, Jin S, Barnnet M, Freimann S, Van den Hurk R, Feldberg D, et al. Immunocytochemical detection and RT--PCR expression of leukaemia inhibitory factor and its receptor in human fetal and adult ovaries. Mol Hum Reprod. 2004;10 (5):313-9.

(36.) Da Nobrega JE, Goncalves PBD, Chaves RN, Magalhaes DdM, Rossetto R, Lima-Verde IB, et al. Leukemia inhibitory factor stimulates the transition of primordial to primary follicle and supports the goat primordial follicle viability in vitro. Zygote-The Biology of Gametes and Early Embryos. 2012; 20(1):73-8.

(37.) Haidari K, Salehnia M, Rezazadeh Valojerdi M. The effect of leukemia inhibitory factor and coculture on the in vitro maturation and ultrastructure of vitrified and nonvitrified isolated mouse preantral follicles. Fertil Steril. 2008;90(6):2389-97.

(38.) Kong HS, Kim EJ, Youm HW, Kim SK, Lee JR, Suh CS, et al. Improvement in ovarian tissue quality with supplementation of antifreeze protein during warming of vitrified mouse ovarian tissue. Yonsei Med J. 2018;59(2):331-6.

(39.) Lalitkumar S, Boggavarapu NR, Menezes J, Dimitriadis E, Zhang JG, Nicola NA, et al. Polyethylene glycated leukemia inhibitory factor antagonist inhibits human blastocyst implantation and triggers apoptosis by down-regulating embryonic AKT. Fertil Steril. 2013;100(4):1160-9.

(40.) Townson DH, Combelles CM. Ovarian follicular atresia. Basic gynecology some related issues in tech. 2012:156.

(41.) Yang R, Xu S, Zhao Z, Li J. Fas ligand expression and mediated activation of an apoptosis program in bovine follicular granulosa cells. Gene. 2012;493 (1):148-54.

(42.) Tilly J, Tilly K, Kenton M, Johnson A. Expression of members of the bcl-2 gene family in the immature rat ovary: equine chorionic gonadotropin-mediated inhibition of granulosa cell apoptosis is associated with decreased bax and constitutive bcl-2 and bcl-xlong messenger ribonucleic acid levels. Endocrinology. 1995;136(1):232-41.

(43.) Depalo R, Nappi L, Loverro G, Bettocchi S, Caruso ML, Valentini AM, et al. Evidence of apoptosis in human primordial and primary follicles. Hum Reprod. 2003;18(12):2678-82.

(44.) Yang E, Korsmeyer SJ. Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood. 1996;88(2):386-401.

(45.) Reed JC. Double identity for proteins of the Bcl-2 family. Nature. 1997;387(6635):773-6.

(46.) Tilly JL. Apoptosis and ovarian function. Rev Reprod. 1996;1(3):162-72.

Maasoume Abdollahi (1), Mojdeh Salehnia (1*), Saghar Salehpour (2), Shahram Pour-Beiranvand (1)

(1)- Department of Anatomical Sciences, Medical Sciences Faculty, Tarbiat Modares University, Tehran, Iran

(2)- Infertility and Reproductive Health Research Center (IRHRC), Shahid Beheshti University of Medical Sciences, Tehran, Iran

(*) Corresponding Author: Mojdeh Salehnia, Department of Anatomy, Tarbiat Modares University, P.O. Box: 14115-111, Tehran, Iran.,

Received: Apr. 15, 2018

Accepted: Aug. 8, 2018
Table 1. Oligonucleotide primers

Accession numbers  Gene      Primer sequence

NC_000012.11       GAPDH     Forward: 5'CTGGGCTACACTGAGCACC3'
                             Reverse: 5'AAGTGGTCGTTGAGGGCAATG3'
NC_000010.10       Fas       Forward: 5'TGAAGGACATGGCTTAGAAGTG3'
                             Reverse: 5'GGTGCAAGGGTCACAGTGTT3'
NC_000001.10       FasL      Forward: 5'GCAGCCCTTCAATTACCCAT3'
                             Reverse: 5'CAGAGGTTGGACAGGGAAGAA3'
NC_000018.9        Bcl2      Forward: 5'TTGCTTTACGTGGCCTGTTTC3'
                             Reverse: 5'GAAGACCCTGAAGGACAGCCAT3'
NC_000019.9        Bax       Forward: 5'CCCGAGAGGTCTTTTTCCGAG3'
                             Reverse: 5'CCAGCCCATGATGGTTCTGAT3'
NC_000017.10       p53       Forward: 5'GAGGTTGGCTCTGACTGTACC3'
                             Reverse: 5'TCCGTCCCAGTAGATTACCAC3'
NC_000017.10       BIRC5     Forward: 5'AGGACCACCGCATCTCTACAT3'
                             Reverse: 5'AAGTCTGGCTCGTTCTCAGTG3'
NC_000002.11       caspase8  Forward: 5'ATTTGCCTGTATGCCCGAGC3'
                             Reverse: 5'CCTGAGTGAGTCTGATCCACAC3'
NC_000004.11       caspase3  Forward: 5'AGAGGGGATCGTTGTAGAAGTC3'
                             Reverse: 5'ACAGTCCAGTTCTGTACCACG3'

Accession numbers  PCR product size (bp)

NC_000012.11       101

NC_000010.10       118

NC_000001.10       101

NC_000018.9         94

NC_000019.9        155

NC_000017.10       133

NC_000017.10       118

NC_000002.11       105

NC_000004.11        81

Table 2. The number and percentage of normal follicles at different
developmental stages in all experimental groups

Groups                      Normal F.
                            (%[+ or -]SE)

Non-vitrified- LI[F.sup.-]  27 (76[+ or -]0.5)
Vitrified-LI[F.sup.-]       42 (67.27[+ or -]4.2) (a)
Non-vitrified -LI[F.sup.+]  52 (88.67[+ or -]5.6) (b)
Vitrified- LI[F.sup.+]      43 (86.3[+ or -]3.6) (b)

Groups                      Degenerated F.
                            (%[+ or -]SE)

Non-vitrified- LI[F.sup.-]   9 (24[+ or -]0.2)
Vitrified-LI[F.sup.-]       18 (32.73[+ or -]0.14) (a)
Non-vitrified -LI[F.sup.+]   8 (13.3[+ or -]0.15) (b)
Vitrified- LI[F.sup.+]       7 (14[+ or -]0.11) (b)

Groups                      Primordial F.
                            (%[+ or -]SE)

Non-vitrified- LI[F.sup.-]  21 (79[+ or -]3.5)
Vitrified-LI[F.sup.-]       42 (77.9[+ or -]4.14)
Non-vitrified -LI[F.sup.+]  35 (65.23[+ or -]3.02) (b)
Vitrified- LI[F.sup.+]      28 (64.54[+ or -]4) (b)

Groups                      Primary F.
                            (%[+ or -]SE)

Non-vitrified- LI[F.sup.-]   5 (17.4[+ or -]0.4)
Vitrified-LI[F.sup.-]       10 (18.6[+ or -]0.5)
Non-vitrified -LI[F.sup.+]  13 (24.31[+ or -]0.3) (b)
Vitrified- LI[F.sup.+]      11 (25.3[+ or -]3.5) (b)

Groups                      Growing F.
                            (%[+ or -]SE)

Non-vitrified- LI[F.sup.-]  1 (3.6[+ or -]0.13)
Vitrified-LI[F.sup.-]       3 (3.5[+ or -]0.15)
Non-vitrified -LI[F.sup.+]  6 (10.46[+ or -]0.17) (b)
Vitrified- LI[F.sup.+]      5 (10.16[+ or -]0.17) (b)

All experiments were done at least in 5 repeats and n=5 in each group.
a: Significant differences with the same non-vitrified groups (p<0.05)
b: Significant differences with the same non-LIF treated-cultured
groups (p<0.05)

Table 3. The Level of 17-[beta] estradiol, progesterone and
dehydroepiandrostrone in all cultured groups at days 2 and 14 of
cultivation period

Groups                     17-[beta] estradiol (pg/ml)
                           (Mean[+ or -]SE)
                           Day 2            Day 14

Non-vitrified-LI[F.sup.-]  5725[+ or -]278  8548[+ or -]211 (*)
Vitrified-LI[F.sup.-]      6100[+ or -]656  7899[+ or -]856 (*)
Non-vitrified-LI[F.sup.+]  5829[+ or -]643  28062[+ or -]1003 (a*)
Vitrified-LIF+             5200[+ or -]223  27651[+ or -]587 (a*)

Groups                     Progesterone (ng/ml)
                           (Mean[+ or -]SE)
                           Day 2        Day 14

Non-vitrified-LI[F.sup.-]  63[+ or -]4  83[+ or -]2 (*)
Vitrified-LI[F.sup.-]      60[+ or -]5  75[+ or -]3 (*)
Non-vitrified-LI[F.sup.+]  72[+ or -]8  251[+ or -]12 (a*)
Vitrified-LIF+             68[+ or -]6  245[+ or -]15 (a*)

Groups                     DHEA ([micro]g/ml)
                           (Mean[+ or -]SE)
                           Day 2           Day 14

Non-vitrified-LI[F.sup.-]  184[+ or -]11   169[+ or -]6 (*)
Vitrified-LI[F.sup.-]      176[+ or -]8    158[+ or -]7 (*)
Non-vitrified-LI[F.sup.+]  186[+ or -]15    94[+ or -]3 a (*)
Vitrified-LIF+             170[+ or -]7     98[+ or -]5 (a*)

All experiments were done at least in 3 repeats and n=3 in each group.
(a): Significant differences with the same non-LIF treated-cultured
groups (p<0.05). (*): Significant differences between day 14 and day 2
in the same group (p<0.05)

Table 4. Caspase 3/7 activity in studied groups (mean[+ or -]SE)

Groups                          Caspase 3/7 (RLU/mg protein)

Apoptosis induced mouse tymuse  16370[+ or -]658.49
Non-vitrified-LI[F.sup.-]       13533.33[+ or -]785.98
Vitrified-LI[F.sup.-]           12700[+ or -]351.11
Non-vitrified-LI[F.sup.+]        2158[+ or -]34.034
Vitrified-LI[F.sup.+]            2042[+ or -]70.868

There was no significant difference between groups. All experiments
were done at least in 3 repeats and n=3 in each group

Table 5. The expression of pro-apoptotic genes expression to
housekeeping gene (GAPDH) in studied groups (Mean[+ or -]SE)

Groups                     Fas

Non-vitrified-LI[F.sup.-]  0.0089[+ or -]0.0004
Vitrified-LI[F.sup.-]      0.0215[+ or -]0.0012 (a)
Non-vitrified-LI[F.sup.+]  0.0040[+ or -]0.0067 (b)
Vitrified-LI[F.sup.+]      0.0062[+ or -]0.0001 (a,b)

Groups                     FasL

Non-vitrified-LI[F.sup.-]  0.0173[+ or -]0.002
Vitrified-LI[F.sup.-]      0.0245[+ or -]0.001 (a)
Non-vitrified-LI[F.sup.+]  0.0086[+ or -]0.0003 (b)
Vitrified-LI[F.sup.+]      0.0062[+ or -]0.0001 (a,b)

Groups                     Bax

Non-vitrified-LI[F.sup.-]  0.0007[+ or -]0.0019
Vitrified-LI[F.sup.-]      0.0054[+ or -]0.0032
Non-vitrified-LI[F.sup.+]  0.0037[+ or -]0.0004 (b)
Vitrified-LI[F.sup.+]      0.0044[+ or -]0.0005

Groups                     P53

Non-vitrified-LI[F.sup.-]  0.0142[+ or -]0.0017
Vitrified-LI[F.sup.-]      0.3103[+ or -]0.0019 (a)
Non-vitrified-LI[F.sup.+]  0.0062[+ or -]0.0017 (b)
Vitrified-LI[F.sup.+]      0.0082[+ or -]0.0004 (a,b)

Groups                     Caspase3

Non-vitrified-LI[F.sup.-]  0.0021[+ or -]0.0019
Vitrified-LI[F.sup.-]      0.0052[+ or -]0.0003 (a)
Non-vitrified-LI[F.sup.+]  0.0008[+ or -]0.00009 (b)
Vitrified-LI[F.sup.+]      0.0006[+ or -]0.0001 (a,b)

Groups                     Caspase8

Non-vitrified-LI[F.sup.-]  0.0957[+ or -]0.004
Vitrified-LI[F.sup.-]      0.1062[+ or -]0.006
Non-vitrified-LI[F.sup.+]  0.4620[+ or -]0.002 (b)
Vitrified-LI[F.sup.+]      0.0567[+ or -]0.002 (a,b)

(a): Significant difference with non-vitrified group in respected group
(p<0.05). (b): Significant difference with non-LIF-treated group in
respected group (p<0.05).
All experiments were done at least in 3 repeats and n=3 in each group

Table 6. The expression of anti-apoptotic genes expression to
housekeeping gene (GAPDH) in studied groups (Mean[+ or -]SE)

Groups                     Bcl2                BIRC5

Non-vitrified-LI[F.sup.-]  0.085[+ or -]0.007  0.166[+ or -]0.018
Vitrified-LI[F.sup.-]      0.073[+ or -]0.005  0.149[+ or -]0.018
Non-vitrified-LI[F.sup.+]  0.092[+ or -]0.005  0.301[+ or -]0.028 (a)
Vitrified-LI[F.sup.+]      0.877[+ or -]0.004  0.284[+ or -]0.015 (a)

Groups                     Bax/Bcl2

Non-vitrified-LI[F.sup.-]  0.086[+ or -]0.007
Vitrified-LI[F.sup.-]      0.074[+ or -]0.011
Non-vitrified-LI[F.sup.+]  0.039[+ or -]0.003
Vitrified-LI[F.sup.+]      0.049[+ or -]0.012

(a): Significant difference with non-LIF-treated group in respected
group (p<0.05). All experiments were done at least in 3 repeats and n=3
in each group
COPYRIGHT 2018 Avicenna Research Institute
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2018 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Original Article
Author:Abdollahi, Maasoume; Salehnia, Mojdeh; Salehpour, Saghar; Beiranvand, Shahram Pour
Publication:Journal of Reproduction and Infertility
Article Type:Report
Date:Oct 1, 2018
Previous Article:Male Infertility, Precision Medicine and Systems Proteomics.
Next Article:Evaluating the Potential of Three Sperm Surface Antigens as Egg-adhesion Biomarkers for Human Sperm Selection.

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters